Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
Southwestern Medical Center · The University of Texas Southwestern Medical Center · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
880
total citations
- FWCI
- 34.27
- Percentile
- 100%
- References
- 43
Citations per year
Authors
10- MSMuhammad S. BegCorresponding
Southwestern Medical Center, The University of Texas Southwestern Medical Center
- ABAndrew Brenner
The University of Texas at San Antonio Health Science Center, The University of Texas Health Science Center at Houston
- JCJasgit C. Sachdev
Scottsdale Research Institute (United States)
- MJMitesh J. Borad
Mayo Clinic in Arizona
- YKYoon‐Koo Kang
Asan Medical Center
Topics & keywords
Topics
Keywords
- Medicine
- Nausea
- Neutropenia
- Internal medicine
- Adverse effect
- Gastroenterology
- Vomiting
- Cmax
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.